Think “Lower Is Better” for LDL in Patients at High CV Risk

Debate continues about whether to aim for a specific LDL goal.

For over a decade, the focus has been on using target DOSES of statins shown to reduce CV risk...rather than titrating to an LDL goal.

But there’s been a shift toward a blended approach in recent years.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

  • Cutting-edge advice about new medications and how they fit into practice
  • Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
  • Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote